Ideas worth thinking about.
Questions worth publishing.

Argues that responsible AI in healthcare must be reconceived as clinical-grade decision governance architecture — an operational system in which AI outputs are embedded within structured human-led clinical workflows, with explicit accountability assignment, explainability requirements, and immutable audit trails. Proposes a five-pillar governance model and introduces the governance-by-design principle, with specific reference to the Saudi Arabian regulatory context including PDPL, SDAIA ethics principles, and Vision 2030 digital health transformation goals.

Argues that AI accountability cannot be achieved through post-hoc auditing alone. Governance must be embedded as an intrinsic architectural property of AI systems — built into workflows, decision loops, and accountability mechanisms before deployment, not layered on afterward. Introduces the governance-by-design principle as a foundational requirement for trustworthy AI in high-stakes environments.

Proposes a decision-centric Human-in-the-Loop governance architecture that complements IEEE 7000-2021 by binding ethical accountability to explicit human decision authority at defined control points. Introduces the concepts of decision displacement and authority leakage — where responsibility remains formally human while practical control migrates to automated pipelines.

A comprehensive analysis of the strategic, economic, and technological implications of data localization in Saudi Arabia, situating SADAIA's approach within global trends. Incorporates policy analysis, comparative benchmarking with GDPR, India's DPDP Act, and UAE data laws, alongside sector-specific case studies in fintech, healthtech, and e-commerce.

Proposes an AI framework integrating multimodal digital biomarkers — including continuous glucose monitors, smartwatch metrics, body composition, food intake logs, and sleep quality — to model and optimise individual metabolic states. Applies deep learning, reinforcement learning, and explainable AI (XAI) to predict glycemic responses and generate adaptive recommendations for potential diabetes reversal.